Surface Monitoring Technology to Remove The Mask - Stage 1
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A pilot-stage device feasibility study investigating a mask-free motion-monitoring patient immobilisation system for use during radiation therapy treatment of head and neck cancer (HNC). This mask-free system combines the standard radiation therapy (RT) head rest to help the patient remain still with a surface guidance detection system that uses sensors to detect and track patient movement. Patients who will have RT treatment for head and neck cancer involving an immobilisation mask will be asked to lie on the treatment couch for the normal treatment fraction time while the surface monitoring system is activated. We will then assess: i) The level of acceptance of the system by HNC patients currently being treated with RT using an immobilisation mask, and ii) The ability of the surface guidance system to monitor movement of the patients
Sponsor: University of Sydney
You may qualify if…
- ✓ A diagnosis of head and neck cancer, any stage
- ✓ ≥ 18 years of age
- ✓ ECOG performance status 0-2
- ✓ Receiving radiation therapy for HNC with a thermoplastic immobilisation mask
- ✓ Any other prior therapy allowed
- ✓ Willing and able to comply with all study requirements
- ✓ Must be able to read and complete questionnaires in English
You may not qualify if…
- ✕ People with cognitive impairment which would preclude them from providing informed consent
- ✕ People who are unable to speak and read English and for whom obtaining consent would be difficult.
- ✕ Withdrawal Criteria
- ✕ Participants may withdraw from the study at any time before, during or after participation, and do not have to provide a reason. They may do so by advising any member of the study team, research office or their treating team, by completing the withdrawal of consent form, verbally or in writing.
- ✕ Participants may be withdrawn from the study by the principal investigator, treating physician or attending clinician if they perceive the participant is experiencing or will likely experience physical or mental harm
- ✕ No additional study data will be collected for a participant after they withdraw from the study
- ✕ Withdrawing participants' data will be used unless the participant specifies they no longer give permission for the data to be stored or used, however, their data will not be removed from any analysis or publication that has already occurred, or from study databases once it has been de-identified
- ✕ Participant will be replaced if they withdraw or are withdrawn from the study prior to starting the second couch session. This will be done by recruitment of an additional participant.
Source: ClinicalTrials.gov · NCT04266223 · last updated 2024-07-09